GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve Pursuant to clause 33 of the Listing Obligations and Disclosure Requirements Regulations,2015 (LODR), this is to inform you that a meeting of the Board of Directors of our Company will be held on Friday, 5th February 2021, inter-alia, to consider approval of Un-audited financial results for the quarter and nine months ended 31 st December 2020.
|